Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trovati, M.
Right arrow Articles by Anfossi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trovati, M.
Right arrow Articles by Anfossi, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 11 1318-1322, Copyright © 1995 by American Diabetes Association


ARTICLES

Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients

M Trovati, EM Mularoni, S Burzacca, MC Ponziani, P Massucco, L Mattiello, V Piretto, F Cavalot and G Anfossi
Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.

To investigate the effects of insulin on platelets in obesity and in non-insulin-dependent diabetes mellitus (NIDDM)--classic insulin-resistant states--we determined ADP-induced platelet aggregation and platelet cGMP (guanosine 3',5'-cyclic monophosphate) content in platelet-rich plasma obtained from nine obese subjects and nine age-matched healthy volunteers and from eight NIDDM obese patients and nine age-matched healthy volunteers after a 3-min incubation with human recombinant insulin (0, 240, 480, 960, and 1,920 pmol/l). Platelet aggregation was evaluated using different ADP doses to measure the ADP concentration determined on the basis of a dose-response curve necessary to elicit a maximal aggregation of 50% (ED50). Insulin induced a dose-dependent decrease of platelet aggregation to ADP (P = 0.0001) in healthy subjects. A significant effect was evident starting from an insulin concentration of 240 pmol/l. On the contrary, in insulin-resistant subjects, insulin reduced platelet sensitivity to ADP only at a concentration of 1,920 pmol/l. When ADP ED50 values obtained in platelet-rich plasma incubated with insulin were expressed in percentage of the ADP ED50 values obtained in platelet-rich plasma without insulin, considered as 100%, we observed that ADP ED50 with 1,920 pmol/l insulin was 153.6 +/- 13.2% in the younger healthy subject group (P = 0.004), 150.0 +/- 3.8% in the older healthy subject group (P = 0.0001), 116.1 +/- 6.1% in obese subjects (P = 0.031), and 120.0 +/- 8.6% in NIDDM patients (P = 0.05). In healthy subjects, insulin induced a dose-dependent increase of platelet cGMP (P = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
I. Russo, P. Del Mese, G. Doronzo, A. De Salve, M. Secchi, M. Trovati, and G. Anfossi
Platelet Resistance to the Antiaggregatory Cyclic Nucleotides in Central Obesity Involves Reduced Phosphorylation of Vasodilator-Stimulated Phosphoprotein
Clin. Chem., June 1, 2007; 53(6): 1053 - 1060.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
F. Dentali, E. Romualdi, and W. Ageno
The metabolic syndrome and the risk of thrombosis
Haematologica, March 1, 2007; 92(3): 297 - 299.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Basili, G. Pacini, M. T. Guagnano, M. R. Manigrasso, F. Santilli, C. Pettinella, G. Ciabattoni, C. Patrono, and G. Davi
Insulin Resistance as a Determinant of Platelet Activation in Obese Women
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2531 - 2538.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev., February 1, 2004; 25(1): 153 - 175.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, et al.
HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective data from the Verona Diabetes Complications Study
Diabetes Care, July 1, 2002; 25(7): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Westerbacka, H. Yki-Jarvinen, A. Turpeinen, A. Rissanen, S. Vehkavaara, M. Syrjala, and R. Lassila
Inhibition of Platelet-Collagen Interaction: An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 167 - 172.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. I. Vinik, T. Erbas, T. S. Park, R. Nolan, and G. L. Pittenger
Platelet Dysfunction in Type 2 Diabetes
Diabetes Care, August 1, 2001; 24(8): 1476 - 1485.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Westerbacka, I. Wilkinson, J. Cockcroft, T. Utriainen, S. Vehkavaara, and H. Yki-Jarvinen
Diminished Wave Reflection in the Aorta : A Novel Physiological Action of Insulin on Large Blood Vessels
Hypertension, May 1, 1999; 33(5): 1118 - 1122.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Bonora, J. Willeit, S. Kiechl, F. Oberhollenzer, G. Egger, R. Bonadonna, and M. Muggeo
Relationship Between Insulin and Carotid Atherosclerosis in the General Population : The Bruneck Study
Stroke, June 1, 1997; 28(6): 1147 - 1152.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.